Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Cognition Therapeutics Inc’s current trading price is 18.57% away from its 52-week high, while its distance from the 52-week low is 1164.05%. The stock’s price range during this period has varied between $0.22 and $2.37. The company, active in the Healthcare sector, saw a trading volume of around 20.73 million for the day, considerably higher average daily volume of 9.69 million observed over the last three months.
Cognition Therapeutics Inc (CGTX) currently has a stock price of $2.81. The stock saw a sharp increase in the last trading session, hitting a high of $4.0 after opening at $2.81. The lowest recorded price for the day was $2.0 before it closed at $1.99.
In terms of market performance, Cognition Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $2.37 on 08/22/25, while the lowest value was $0.22 on 05/28/25.
How Financial Performance Impacts Market Capitalization
Cognition Therapeutics Inc (CGTX) has experienced a quarterly rise of 792.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 206.45M and boasts a workforce of 28 employees.
Decoding Analysts’ Ratings for Cognition Therapeutics Inc
As of right now, 3 analysts are rating Cognition Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.55, with a change in price of +2.39. Similarly, Cognition Therapeutics Inc recorded 6,601,106 in trading volume during the last 100 days, posting a change of +567.78%.
How CGTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CGTX stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.03.
CGTX Stock Stochastic Average
As of today, the raw stochastic average of Cognition Therapeutics Inc over the past 50 days is 97.71%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 97.41%. Additionally, the Stochastic %K and %D values for the company were 90.63% and 85.05%, respectively, over the past 20 days.
CGTX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a gain of 267.08%.However, over the last six months, we can see a weaker performance of 381.82%. Over the last 30 days, the price of CGTX has fallen by 226.14%. And in the last five days, it has surged by 82.47%.
